NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics

Xenarthrans – anteaters, sloths, and armadillos – have essential functions for ecosystem maintenance, such as insect control and nutrient cycling, playing key roles as ecosystem engineers. Because of habitat loss and fragmentation, hunting pressure, and conflicts with 24 domestic dogs, these species have been threatened locally, regionally, or even across their full distribution ranges. The Neotropics harbor 21 species of armadillos, ten anteaters, and six sloths. Our dataset includes the families Chlamyphoridae (13), Dasypodidae (7), Myrmecophagidae (3), Bradypodidae (4), and Megalonychidae (2). We have no occurrence data on Dasypus pilosus (Dasypodidae). Regarding Cyclopedidae, until recently, only one species was recognized, but new genetic studies have revealed that the group is represented by seven species. In this data-paper, we compiled a total of 42,528 records of 31 species, represented by occurrence and quantitative data, totaling 24,847 unique georeferenced records. The geographic range is from the south of the USA, Mexico, and Caribbean countries at the northern portion of the Neotropics, to its austral distribution in Argentina, Paraguay, Chile, and Uruguay. Regarding anteaters, Myrmecophaga tridactyla has the most records (n=5,941), and Cyclopes sp. has the fewest (n=240). The armadillo species with the most data is Dasypus novemcinctus (n=11,588), and the least recorded for Calyptophractus retusus (n=33). With regards to sloth species, Bradypus variegatus has the most records (n=962), and Bradypus pygmaeus has the fewest (n=12). Our main objective with Neotropical Xenarthrans is to make occurrence and quantitative data available to facilitate more ecological research, particularly if we integrate the xenarthran data with other datasets of Neotropical Series which will become available very soon (i.e. Neotropical Carnivores, Neotropical Invasive Mammals, and Neotropical Hunters and Dogs). Therefore, studies on trophic cascades, hunting pressure, habitat loss, fragmentation effects, species invasion, and climate change effects will be possible with the Neotropical Xenarthrans dataset

Highly-parallelized simulation of a pixelated LArTPC on a GPU

The rapid development of general-purpose computing on graphics processing units (GPGPU) is allowing the implementation of highly-parallelized Monte Carlo simulation chains for particle physics experiments. This technique is particularly suitable for the simulation of a pixelated charge readout for time projection chambers, given the large number of channels that this technology employs. Here we present the first implementation of a full microphysical simulator of a liquid argon time projection chamber (LArTPC) equipped with light readout and pixelated charge readout, developed for the DUNE Near Detector. The software is implemented with an end-to-end set of GPU-optimized algorithms. The algorithms have been written in Python and translated into CUDA kernels using Numba, a just-in-time compiler for a subset of Python and NumPy instructions. The GPU implementation achieves a speed up of four orders of magnitude compared with the equivalent CPU version. The simulation of the current induced on 10^3 pixels takes around 1 ms on the GPU, compared with approximately 10 s on the CPU. The results of the simulation are compared against data from a pixel-readout LArTPC prototype

Neoadjuvant Chemoradiotherapy And Surgery Compared With Surgery Alone In Squamous Cell Carcinoma Of The Esophagus [radioterapia E Quimioterapia Neoadjuvantes E Cirurgia Comparado Com A Cirurgia No Tratamento Do Carcinoma Epidermoide Do Esôfago]

Context - Despite progress in recent years in methods of diagnosis and surgical treatment of esophageal cancer, there is still controversy about the benefits from neoadjuvant chemoradiotherapy. Objective - To analise the survival of patients submitted to esophagectomy for squamous cell carcinoma of the esophagus with or without neoadjuvant chemoradiotherapy. Method - A retrospective, non-randomized study conducted using the medical charts of patients operated for squamous cell carcinoma of the esophagus at the School of Medical Sciences, University of Campinas (UNICAMP), Campinas, São Paulo, Brazil between 1979 and 2006. The Kaplan-Meier analysis was used to calculate survival curves and the log-rank test to compare data in each group. The significance level was settled as 5%. Results - A total of 123 patients were evaluated in this study, divided into three groups: I - 26 (21.2%) patients submitted to esophagectomy alone; II - 81 (65.8%) patients submitted to neoadjuvant radiotherapy plus esophagectomy and III - 16 (13%) patients submitted to neoadjuvant chemoradiotherapy plus esophagectomy. A statistically significant survival was recorded between the groups (log rank = 6.007; P = 0.05), survival being greatest in the group submitted to neoadjuvant chemoradiotherapy, followed by the group submitted to neoadjuvant radiotherapy compared to the group submitted to esophagectomy alone as the initial treatment of choice. Conclusion - Radiotherapy and chemotherapy neoadjuvants in patients with squamous cell carcinoma of the esophagus offers benefits and increases survival.502101106Almhanna, K., Strosberg, J.R., Multimodality approach for locally advanced esoph-ageal cancer (2012) World J Gastroenterol, 18, pp. 5679-5687Ancona, E., Ruol, A., Santi, S., Merigliano, S., Sileni, V.C., Koussis, H., Zaninotto, G., Peracchia, A., Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esopagheal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone (2001) Cancer, 91, pp. 2165-2174Bosset, J.F., Gignoux, M., Triboulet, J.P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Sahmoud, T., Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus (1997) N Engl J Med, 337, pp. 161-167(2012) Rio De Janeiro, , http://www.inca.gov.br/estimativa/2012/, Brasil. Ministério da Saúde, National Institute of Cancer (INCA): Incidence of cancer in Brazil [Internet]Conteduca, V., Sansonno, D., Ingravallo, G., Marangi, S., Russi, S., Lauletta, G., Dam-Macco, F., Barrett's esophagus and esophageal cancer: An overview (2012) Int J Oncol, 41, pp. 414-424de Barros, S.G., Ghisolf, E.S., Luz, L.P., Barlem, G.G., Vidal, R.M., Wolff, F.H., Magno, V.A., Prolla, J.C., High temperature "matè" infusion drinking in a population at risk for squamous cell carcinoma of the esophagus (2000) Arq Gastroenterol, 37, pp. 25-30Denlinger, C.E., Reed, C.E., Contemporary management of esophageal malignancy (2012) Surg Clin North Am, 92, pp. xvii-xviiiEl-Nakadi, I., Van Laethem, J.L., Houben, J.J., Gay, F., Closset, J., van Houtte, P., Danhier, S., Gelin, M., Squamous cell carcinoma of the esophagus: Multimodal therapy in locally advanced disease (2002) World J Surg, 26, pp. 72-78Fiorica, F., Di Bona, D., Schepis, F., Licata, A., Shahied, L., Venturi, A., Falchi, A.M., Cammà, C., Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis (2004) Gut, 53, pp. 925-930Greer, S.E., Goodney, P.P., Sutton, J.E., Birkmeyer, J.D., Neoadjuvant chemoradio-therapy for esophageal carcinoma: A meta-analysis (2005) Surgery, 137, pp. 172-177Hölscher, A.H., Bollschweiler, E., Choosing the best treatment for esophageal cancer: Criteria for selecting the best multimodal therapy (2012) Recent Results Cancer Res, 196, pp. 169-177Le Prise, E., Etienne, P.L., Meunier, B., Maddern, G., Ben Hassel, M., Gedouin, D., Boutin, D., Launois, B., A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus (1994) Cancer, 73, pp. 1779-1784Liao, Z., Zhang, Z., Jin, J., Ajani, J.A., Swisher, S.G., Stevens, C.W., Ho, L., Komaki, R., Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients (2004) Int J Radiat Oncol Biol Phys, 60, pp. 1484-1493Makary, M.A., Kiernan, P.D., Sheridan, M.J., Tonnesen, G., Hetrick, V., Vaughan, B., Graling, P., Elster, E., Multimodality treatment for esophageal cancer: The role of surgery and neoadjuvant therapy (2003) Am Surg, 69, pp. 693-700Malaisrie, S.C., Untch, B., Aranha, G.V., Mohideen, N., Hantel, A., Pickleman, J., Neo-adjuvant chemoradiotherapy for locally advanced esophageal cancer: Experience at a single institution (2004) Arch Surg, 139, pp. 532-538Malthaner, R.A., Wong, R.K., Rumble, R.B., Zuraw, L., Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis (2004) BMC Med, 2, p. 35Marin, F.A., Lamônica-Garcia, V.C., Henry, M.A., Burini, R.C., Grade of esophageal cancer and nutritional status impact on postsurgery outcomes (2010) Arq Gastroenterol, 47, pp. 348-353Morgan, M.A., Lewis, W.G., Crosby, T.D., Escofet, X., Roberts, S.A., Brewster, A.E., Harvard, T.J., Clark, G.W., Prospective cohort comparison of neoadjuvant chemo-radiotherapy versus chemotherapy in patients with oesophageal cancer (2007) Br J Surg, 94, pp. 1509-1514Pinotti, H.W., Subtotal esophagectomy by transmediastinal tunnel without thora-cotomy (1977) Rev Assoc Med Bras, 23, pp. 395-398Ramos, A.C., Araujo, M.R., Lopes, L.R., Andreollo, N.A., Role of the vitamin C in diethylnitrosamine-induced esophageal cancer in Wistar rats (2009) Acta Cir Bras, 24, pp. 183-188Schena, M., la Rovere, E., Solerio, D., Bustreo, S., Barone, C., Daniele, L., Buffoni, L., Ricardi, U., Neoadjuvant che-mo-radiotherapy for locally advanced esophageal cancer: A monocentric study (2012) Tumori, 98, pp. 451-457Sugimachi, K., Yaita, A., Ueo, H., Natsuda, Y., Inokuchi, K., A safer and more reliable operative technique for esophageal reconstruction using a gastric tube (1980) Am J Surg, 140, pp. 471-474Talsma, K., van Hagen, P., Grotenhuis, B.A., Steyerberg, E.W., Tilanus, H.W., van Lanschot, J.J., Wijnhoven, B.P., Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer (2012) Ann Surg Oncol, 19, pp. 2142-2148Tercioti, V., Lopes, L.R., Coelho-Neto, J.S., Andreollo, N.A., New aspects of the neo-adjuvant therapy in esophageal squamous cell carcinoma: A review of medical literature (2009) ABCD Arq Bras Cir Dig, 22, pp. 33-40Urba, S.G., Orringer, M.B., Turrisi, A., Iannettoni, M., Forastiere, A., Strawderman, M., Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma (2001) J Clin Oncol, 19, pp. 305-313Urschel, J.D., Vasan, H., A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer (2003) Am J Surg, 185, pp. 538-543van Hagen, P., Hulshof, M.C., van Lanschot, J.J., Steyerberg, E.W., Van Berge Henegou-Wen, M.I., Wijnhoven, B.P., Richel, D.J., van der Gaast, A., CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer (2012) N Engl J Med, 366, pp. 2074-2084Worni, M., Martin, J., Gloor, B., Pietrobon, R., D'Amico, T.A., Akushevich, I., Berry, M.F., Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008 (2012) J Am Coll Surg, 215, pp. 643-651Zhang, X., Watson, D.I., Jamieson, G.G., Bessell, J.R., Devitt, P.G., Neoadjuvant chemo-radiotherapy for esophageal carcinoma (2005) Dis Esophagus, 18, pp. 104-10